ITC starts clinical trials of nasal spray to prevent COVID-19
ITC Nasal spray can be effective in preventing infection as well as transmission of Covid-19. The internal trials found it to be effective against other viruses like the common cold.
ITC Nasal spray: A diversified Indian company, ITC Limited, confirmed on November 25, 2021 that it has begun clinical trials of a nasal spray that can prevent COVID-19 infection.
The nasal spray has reportedly been developed by ITC Life Sciences and Technology Centre in Bengaluru. The internal trials have found the nasal spray to be effective against other viruses like the common cold.
The ITC spokesperson while confirming the development said that they are unable to share more details at the current moment as the clinical trials are underway.
ITC Nasal Spray significance
If clinical trials show that ITC's nasal spray can prevent COVID-19 infection, it will hugely aid the reopening of schools, colleges, offices and public transport at full strength and return to normalcy.
ITC Nasal Spray: All you need to know!
•ITC Nasal spray is said to have the potential to be effective in preventing infection as well as transmission of Covid-19.
•Internal trials found it to be effective against other viruses like the common cold.
•ITC has received approvals from the ethics committees and has registered its clinical trials with Clinical Trial Registry - India (CTRI).
•The clinical trials of the nasal spray would take about three months.
|ITC had launched several products amid the COVID-19 pandemic including masks, disinfectant sprays and wipes under the Savlon brand to meet the requirements of the consumers. The diversified conglomerate has over 350 scientists working on six research platforms- health & wellness, sustainable packaging, beauty & hygiene, consumer & sensory sciences, agroforestry & crop sciences and measurement sciences.|
List of Other Nasal/ Mouth Sprays
Antimicrobial nasal and mouth sprays have been gaining popularity in recent months and several pharma majors are trying to come out with products to meet the demand.
Here is a list of nasal/ mouth sprays launched by other pharma companies to prevent COVID-19-
1. Cipla's Nasal Spray
Cipla launched Naselin antiviral nasal spray with povidone-iodine that can act as the first line of defense against the SARS-CoV-2 virus.
The nasal spray has anti-viral, anti-fungal and anti-bacterial properties that can offer protection against viruses that cause common upper respiratory tract illnesses like flu, cold or sinusitis.
2. Glenmark's nasal spray
Glenmark has partnered with Canadian biotech firm SaNOtize to manufacture, market and distribute its nasal spray- NONS -for Covid-19 treatment.
The pharma major aims to launch the nasal spray under the brand name- Fabispray by second half of 2021-2022.
The phase 3 trials of Glenmark's nasal spray are being conducted to see its effectiveness against Covid-19.
3. Cadila's mouth spray
Cadila Healthcare has also developed Viroshield, an enzyme-based mouth spray. The product has not been launched commercially.
The enzyme-based mouth spray has been formulated in a way to break viral proteins, creating a protective barrier that will guard the mouth and throat against different viruses.
How do the nasal sprays work?
The nasal sprays generally work by killing pathogens in the upper airways, preventing the virus from incubating and spreading to the lungs.
Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app
एग्जाम की तैयारी के लिए ऐप पर वीकली टेस्ट लें और दूसरों के साथ प्रतिस्पर्धा करें। डाउनलोड करें करेंट अफेयर्स ऐपAndroidIOS